Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Grey Wolf Animal Health Corp ( (TSE:WOLF) ).
Grey Wolf Animal Health Corp reported a 31% increase in revenue for the first quarter of 2025, reaching $7.9 million, driven primarily by a 66.1% growth in its Pharmacy business due to increased sales of compounded products and the acquisition of the Compounding Pharmacy of Manitoba. Despite a decline in its Animal Health business, the company saw a 47.4% rise in adjusted EBITDA to $1.3 million, indicating strong operational performance and strategic growth initiatives.
More about Grey Wolf Animal Health Corp
Grey Wolf Animal Health Corp is a Canadian diversified health company that operates in the animal and human pharmacy sectors. The company focuses on providing compounded products and has recently expanded its market presence with the acquisition of the Compounding Pharmacy of Manitoba.
Average Trading Volume: 10,363
Technical Sentiment Signal: Hold
Current Market Cap: C$30.77M
For a thorough assessment of WOLF stock, go to TipRanks’ Stock Analysis page.